Label: MODEL AA-8565CV-ACT MODEL AA-8565CV- kit
- NHRIC Code(s): 27860-013-16
- Packager: Aerospace Accessory Service, Inc
- This is a repackaged label.
- Source NDC Code(s): 50844-957
- Category: MEDICAL DEVICE
- DEA Schedule: None
- Marketing Status: Exempt device
Drug Label Information
Updated May 18, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Aerospace Accessory Service
-
INGREDIENTS AND APPEARANCE
MODEL AA-8565CV-ACT MODEL AA-8565CV
emergency response safety kit kitProduct Information Product Type MEDICAL DEVICE Item Code (Source) NHRIC:27860-013 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NHRIC:27860-013-16 1 in 1 PACKAGE; Type 1: Convenience Kit of Co-Package Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 Part 2 1 Part 3 1 Part 4 1 Part 5 1 Part 6 1 Part 7 1 Part 8 1 Part 9 1 Part 10 1 Part 11 1 Part 12 1 Part 13 1 Part 14 1 Part 15 1 Part 16 1 Part 17 1 Part 18 1 Part 19 1 Part 20 1 Part 21 1 Part 22 1 Part 23 1 Part 24 1 Part 25 1 Part 26 1 Part 27 1 Part 28 1 Part 29 1 Part 30 1 Part 31 1 Part 1 of 31 SODIUM CHLORIDE
sodium chloride injection, solutionProduct Information Item Code (Source) NDC:0338-0049 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) SODIUM CHLORIDE 9 g in 1000 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA016677 12/09/1970 Part 2 of 31 SODIUM CHLORIDE
sodium chloride injection, solutionProduct Information Item Code (Source) NDC:0264-7800 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) SODIUM CHLORIDE 0.9 g in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA019635 03/09/1988 Part 3 of 31 ATROPINE SULFATE
atropine sulfate injection, solutionProduct Information Item Code (Source) NDC:0409-4910 Route of Administration INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, ENDOTRACHEAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) ATROPINE SULFATE 0.1 mg in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) SODIUM HYDROXIDE (UNII: 55X04QC32I) SULFURIC ACID (UNII: O40UQP6WCF) WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021146 01/19/2006 Part 4 of 31 ATROPINE SULFATE
atropine sulfate injectionProduct Information Item Code (Source) NDC:76329-3339 Route of Administration PARENTERAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Atropine Sulfate (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) Atropine Sulfate 0.1 mg in 1 mL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/2000 Part 5 of 31 DEXTROSE MONOHYDRATE
dextrose monohydrate injectionProduct Information Item Code (Source) NDC:76329-3301 Route of Administration PARENTERAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE 500 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/2000 Part 6 of 31 DEXTROSE
dextrose monohydrate injection, solutionProduct Information Item Code (Source) NDC:0409-6648 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE 25 g in 50 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) SODIUM HYDROXIDE (UNII: 55X04QC32I) HYDROCHLORIC ACID (UNII: QTT17582CB) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA019445 12/02/2005 Part 7 of 31 NITROGLYCERIN
nitroglycerin tabletProduct Information Item Code (Source) NDC:68462-639 Route of Administration SUBLINGUAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NITROGLYCERIN (UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3) NITROGLYCERIN 0.4 mg Inactive Ingredients Ingredient Name Strength CALCIUM STEARATE (UNII: 776XM7047L) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) SILICA DIMETHYL SILYLATE (UNII: EU2PSP0G0W) Product Characteristics Color white (white to off white) Score no score Shape ROUND (Flat faced) Size 4mm Flavor Imprint Code 2;C Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA206391 08/19/2017 Part 8 of 31 DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride injectionProduct Information Item Code (Source) NDC:0641-0376 Route of Administration INTRAMUSCULAR, INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIPHENHYDRAMINE HYDROCHLORIDE 50 mg in 1 mL Inactive Ingredients Ingredient Name Strength BENZETHONIUM CHLORIDE (UNII: PH41D05744) WATER (UNII: 059QF0KO0R) SODIUM HYDROXIDE (UNII: 55X04QC32I) HYDROCHLORIC ACID (UNII: QTT17582CB) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA080817 11/27/1972 Part 9 of 31 EPINEPHRINE
epinephrine injection, solution, concentrateProduct Information Item Code (Source) NDC:54288-103 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Epinephrine (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH) Epinephrine 1 mg in 1 mL Inactive Ingredients Ingredient Name Strength Sodium Chloride (UNII: 451W47IQ8X) Hydrochloric Acid (UNII: QTT17582CB) Water (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA205029 08/08/2014 Part 10 of 31 ALCOHOL PREP
isopropyl alcohol swabProduct Information Item Code (Source) NDC:67777-121 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ISOPROPYL ALCOHOL (UNII: ND2M416302) (ISOPROPYL ALCOHOL - UNII:ND2M416302) ISOPROPYL ALCOHOL 0.7 mL in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part333A 07/01/2010 Part 11 of 31 MOORE MEDICAL NON ASPIRIN
acetaminophen tablet, film coatedProduct Information Item Code (Source) NDC:55670-467 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN 325 mg Inactive Ingredients Ingredient Name Strength HYPROMELLOSES (UNII: 3NXW29V3WO) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE, UNSPECIFIED (UNII: FZ989GH94E) SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) STARCH, CORN (UNII: O8232NY3SJ) STEARIC ACID (UNII: 4ELV7Z65AP) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color white (white) Score no score Shape ROUND (ROUND) Size 10mm Flavor Imprint Code AZ;234 Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part343 12/30/2008 Part 12 of 31 ASPIRIN
aspirin tablet, film coatedProduct Information Item Code (Source) NDC:55670-131 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN 325 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) HYPROMELLOSES (UNII: 3NXW29V3WO) MINERAL OIL (UNII: T5L8T28FGP) STARCH, CORN (UNII: O8232NY3SJ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color white (white) Score no score Shape ROUND (ROUND) Size 10mm Flavor Imprint Code TCL;011 Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part343 12/30/2008 08/31/2022 Part 13 of 31 MOOREBRAND ASPIRIN
aspirin tablet, film coatedProduct Information Item Code (Source) NDC:55670-616(NDC:50844-957) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN 325 mg Inactive Ingredients Ingredient Name Strength STARCH, CORN (UNII: O8232NY3SJ) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) Product Characteristics Color white Score no score Shape ROUND Size 10mm Flavor Imprint Code Aspirin;44;157 Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part343 10/05/2020 Part 14 of 31 VENTOLIN HFA
albuterol sulfate aerosol, meteredProduct Information Item Code (Source) NDC:0173-0682 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 90 ug Inactive Ingredients Ingredient Name Strength NORFLURANE (UNII: DH9E53K1Y8) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020983 06/09/2006 Part 15 of 31 ALBUTEROL SULFATE HFA
albuterol sulfate aerosol, meteredProduct Information Item Code (Source) NDC:66993-019 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 90 ug Inactive Ingredients Ingredient Name Strength NORFLURANE (UNII: DH9E53K1Y8) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA authorized generic NDA020983 01/15/2019 Part 16 of 31 ALBUTEROL SULFATE
albuterol sulfate aerosol, meteredProduct Information Item Code (Source) NDC:45802-088 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 90 ug Inactive Ingredients Ingredient Name Strength ALCOHOL (UNII: 3K9958V90M) NORFLURANE (UNII: DH9E53K1Y8) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA203760 02/26/2020 Part 17 of 31 ALBUTEROL SULFATE HFA
albuterol sulfate aerosol, meteredProduct Information Item Code (Source) NDC:0093-3174 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 90 ug Inactive Ingredients Ingredient Name Strength NORFLURANE (UNII: DH9E53K1Y8) ALCOHOL (UNII: 3K9958V90M) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021457 01/16/2019 Part 18 of 31 ALBUTEROL SULFATE
albuterol sulfate inhalantProduct Information Item Code (Source) NDC:69097-142 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 108 ug Inactive Ingredients Ingredient Name Strength OLEIC ACID (UNII: 2UMI9U37CP) NORFLURANE (UNII: DH9E53K1Y8) ALCOHOL (UNII: 3K9958V90M) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209959 04/08/2020 Part 19 of 31 ALBUTEROL SULFATE
albuterol sulfate aerosol, meteredProduct Information Item Code (Source) NDC:0254-1007 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 108 ug Inactive Ingredients Ingredient Name Strength OLEIC ACID (UNII: 2UMI9U37CP) NORFLURANE (UNII: DH9E53K1Y8) ALCOHOL (UNII: 3K9958V90M) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA authorized generic NDA020503 04/03/2019 Part 20 of 31 PROAIR HFA
albuterol sulfate aerosol, meteredProduct Information Item Code (Source) NDC:59310-579 Route of Administration RESPIRATORY (INHALATION) Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) ALBUTEROL 90 ug Inactive Ingredients Ingredient Name Strength NORFLURANE (UNII: DH9E53K1Y8) ALCOHOL (UNII: 3K9958V90M) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021457 12/03/2012 Part 21 of 31 POVIDONE-IODINE
povidone-iodine solutionProduct Information Item Code (Source) NDC:46414-7777 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4) IODINE 10 mg in 1 mL Inactive Ingredients Ingredient Name Strength CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F) NONOXYNOL-9 (UNII: 48Q180SH9T) SODIUM HYDROXIDE (UNII: 55X04QC32I) WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part333A 02/14/1976 Part 22 of 31 BZK PADS
benzalkonium chloride swabProduct Information Item Code (Source) NDC:67777-245 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE 1.3 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part333A 04/05/2011 Part 23 of 31 SOLU-CORTEF
hydrocortisone sodium succinate injection, powder, for solutionProduct Information Item Code (Source) NDC:0009-0825 Route of Administration INTRAMUSCULAR, INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROCORTISONE SODIUM SUCCINATE (UNII: 50LQB69S1Z) (HYDROCORTISONE - UNII:WI4X0X7BPJ) HYDROCORTISONE 100 mg in 2 mL Inactive Ingredients Ingredient Name Strength SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU) SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA009866 04/27/1955 Part 24 of 31 SOLU-CORTEF
hydrocortisone sodium succinate injection, powder, for solutionProduct Information Item Code (Source) NDC:0009-0011 Route of Administration INTRAMUSCULAR, INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROCORTISONE SODIUM SUCCINATE (UNII: 50LQB69S1Z) (HYDROCORTISONE - UNII:WI4X0X7BPJ) HYDROCORTISONE 100 mg in 2 mL Inactive Ingredients Ingredient Name Strength SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU) SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA009866 04/27/1955 Part 25 of 31 FUROSEMIDE
furosemide injection, solutionProduct Information Item Code (Source) NDC:23155-473 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) FUROSEMIDE 10 mg in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) SODIUM HYDROXIDE (UNII: 55X04QC32I) HYDROCHLORIC ACID (UNII: QTT17582CB) WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA203428 09/02/2014 Part 26 of 31 FUROSEMIDE
furosemide injection, solutionProduct Information Item Code (Source) NDC:63323-280 Route of Administration INTRAVENOUS, INTRAMUSCULAR Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) FUROSEMIDE 10 mg in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) SODIUM HYDROXIDE (UNII: 55X04QC32I) HYDROCHLORIC ACID (UNII: QTT17582CB) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA018902 07/12/2000 Part 27 of 31 FUROSEMIDE
furosemide injection, solutionProduct Information Item Code (Source) NDC:36000-283 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) FUROSEMIDE 10 mg in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) SODIUM HYDROXIDE (UNII: 55X04QC32I) HYDROCHLORIC ACID (UNII: QTT17582CB) WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA202747 02/06/2014 Part 28 of 31 PITOCIN
oxytocin injectionProduct Information Item Code (Source) NDC:42023-116 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OXYTOCIN (UNII: 1JQS135EYN) (OXYTOCIN - UNII:1JQS135EYN) OXYTOCIN 10 [iU] in 1 mL Inactive Ingredients Ingredient Name Strength ACETIC ACID (UNII: Q40Q9N063P) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA018261 02/01/2008 Part 29 of 31 OXYTOCIN
oxytocin injection, solutionProduct Information Item Code (Source) NDC:63323-012 Route of Administration INTRAVENOUS, INTRAMUSCULAR Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OXYTOCIN (UNII: 1JQS135EYN) (OXYTOCIN - UNII:1JQS135EYN) OXYTOCIN 10 [USP'U] in 1 mL Inactive Ingredients Ingredient Name Strength ACETIC ACID (UNII: Q40Q9N063P) CHLOROBUTANOL (UNII: HM4YQM8WRC) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA018248 08/10/2000 Part 30 of 31 PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride injectionProduct Information Item Code (Source) NDC:0641-1495 Route of Administration INTRAMUSCULAR, INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PROMETHAZINE HYDROCHLORIDE (UNII: R61ZEH7I1I) (PROMETHAZINE - UNII:FF28EJQ494) PROMETHAZINE HYDROCHLORIDE 25 mg in 1 mL Inactive Ingredients Ingredient Name Strength EDETATE DISODIUM (UNII: 7FLD91C86K) CALCIUM CHLORIDE (UNII: M4I0D6VV5M) SODIUM METABISULFITE (UNII: 4VON5FNS3C) PHENOL (UNII: 339NCG44TV) ACETIC ACID (UNII: Q40Q9N063P) SODIUM ACETATE (UNII: 4550K0SC9B) WATER (UNII: 059QF0KO0R) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA083312 09/19/1973 Part 31 of 31 METOPROLOL TARTRATE
metoprolol tartrate tablet, film coatedProduct Information Item Code (Source) NDC:65862-062 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength METOPROLOL TARTRATE (UNII: W5S57Y3A5L) (METOPROLOL - UNII:GEB06NHM23) METOPROLOL TARTRATE 25 mg Inactive Ingredients Ingredient Name Strength MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) STARCH, CORN (UNII: O8232NY3SJ) SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM LAURYL SULFATE (UNII: 368GB5141J) TALC (UNII: 7SEV7J4R1U) MAGNESIUM STEARATE (UNII: 70097M6I30) HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) POLYSORBATE 80 (UNII: 6OZP39ZG8H) Product Characteristics Color white Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code C;73 Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077739 09/11/2007 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date exempt device ABC 01/01/2015 Labeler - Aerospace Accessory Service, Inc (859100547) Registrant - Aerospace Accessory Service, Inc (859100547) Establishment Name Address ID/FEI Business Operations Aerospace Accessory Service, Inc 859100547 manufacture, repack